Mohamed Batterjee

Dr. Mohamed Mazen Batterjee is the Co-Founder, CCO, and investor behind Aumet, an AI-first procurement operating system reshaping pharmaceutical supply chains across the Middle East. A scion of one of Saudi Arabia's oldest pharma dynasties, he parlayed a DBA from IE Business School and 15+ years running Batterjee Pharmaceuticals into co-founding a platform that now connects 12,000+ pharmacies, 1,000+ suppliers, and has processed over $1 billion in GMV. Aumet closed a $12M Series A in May 2026, bringing total funding to $21.84M.